O-12: BUILDING LOCAL CAPACITY FOR HYDROXYUREA PHARMACOKINETICS AND PRECISION DOSING IN LOW-RESOURCE SETTINGS

por L., SMART, M., CHARLES, A., POWER-HAYS, T., HOWARD, K., MCELHINNEY, E., AMBROSE, R., WARE
Publicado 2022

PI-08: HIGH DISEASE BURDEN, MORBIDITY AND MORTALITY AMONG CHILDREN WITH SICKLE CELL ANAEMIA IN UGANDA

por R., NAMAZZI, A., CONROY, C., BOND, M., GOINGS, D., DATTA, R., WARE, R., OPOKA, C., JOHN
Publicado 2022

P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE

por L., SMART, C., SEGBEFIA, T., LATHAM, S., STUBER, K., AMISSAH-ARTHUR, A., LANE, Y., DEI-ADOMAKOH, R., WARE
Publicado 2022

O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE

por A., POWER-HAYS, G., TOMLINSON, L., TSHILOLO, B., SANTOS, T., WILLIAMS, P., OLUPOT-OLUPOT, L., SMART, P., MCGANN, S., STUBER, T., LATHAM, R., WARE
Publicado 2022

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING I...

por POWER-HAYS, A., R., NAMAZZI, C., KATO, A., CONROY, H., HUME, C., JOHN, S., STUBER, MA, A., LANE, T., LATHAM, R., OPOKA, R., WARE
Publicado 2022